Earnings Call · Q2 FY2023·2023-08-10

Q2 23EPS -100.00%*·Rev n/aQ1 23EPS +27.27%·Rev n/aQ4 22EPS -20.17%·Rev n/aQ3 22EPS +18.15%·Rev n/a⚠ consensus missing

X4 Pharmaceuticals, Inc XFOR

Dan Ferry — Host/Moderator

Paula Ragan — Chief Executive Officer

Adam Mostafa — Chief Financial Officer

Murray Stewart — Interim Chief Medical Officer

−36.0%1d on move date−36.0% vs SPY3d−23.8%5d−30.5%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more XFOR calls or request research access.

More XFOR calls Browse calls Request research access